Salivary Gland Poorly Differentiated Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB01254Dasatinib2Completed1
DB00072Trastuzumab2Terminated1